# HBV Vaccine in Anti-core Positive Donors After LT

> **NCT04442841** · PHASE2 · UNKNOWN · sponsor: **Hospital Clinic of Barcelona** · enrollment: 114 (estimated)

## Conditions studied

- Hepatitis B Reactivation

## Interventions

- **BIOLOGICAL:** Hepatitis B vaccine

## Key facts

- **NCT ID:** NCT04442841
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09
- **Primary completion:** 2022-01
- **Final completion:** 2023-01
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2020-07-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04442841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04442841, "HBV Vaccine in Anti-core Positive Donors After LT". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04442841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*